Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer

By afschroeder • November 15, 2025

Sakowitz S, Tupper HI, Benjamin LN, Oh S, He T, Ronaghi R, Channick CL, Rosenberg BJ, Salehi-Rad R, Smith MI, Bando JM, Young TJ, Barjaktarvic I, Velez Velez MA, Gower A, Cummings AL, Goldman J, Lisberg AE, Garon EB, Yanagawa J, Cameron EA, Burt BM, Revels SL, Toste P, Lee JM, Lee A, Deng J, Lee H, Benharash P, Moghanaki D. Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer. Chest. 2025 Nov 12:S0012-3692(25)05681-8. doi: 10.1016/j.chest.2025.10.040. Epub ahead of print. PMID: 41238056.

Tags: Hematology/Oncology, Non-small cell lung cancer, Publications, Pulmonary, Critical Care & Sleep Medicine, Stereotactic Body Radiation Therapy, Surgery, Veterans Administration

cfDNA derived gene signatures as surrogate for microvascular invasion in HCC

Gong R, Wang L, Xue D, Cai J, Jiang Y, Huang J, Zhu J, Li Z, Ke A, Shi G, Wang J, Wang W, Zheng[...]

Utilizing machine learning to identify multimodal signatures for patients who would benefit from the addition of tremelimumab to durvalumab and chemotherapy (TRIDENT)

Skoulidis F, Jabbour SK, Garon EB, Iyengar P, Scagliotti G, Ferrer L, Etchepare G, Gallinato O, Faure J, Bernard P, Colin T, Menu P, Lin[...]

Threading the Needle in Bladder Cancer: A Narrative Review of the Emerging Role of Integrative Oncology in Treatment-Related Adverse Events in the Era of Immunotherapy and Antibody-Drug Conjugates

Niknafs AM, Damron LF, Baclig NV, Iliopoulos M, Drakaki A. Threading the Needle in Bladder Cancer: A Narrative Review of the Emerging Role of Integrative[...]